https://orcid.org/0000-0002-0339-0134
ABSTRACT
We present a 9-month old boy with cystinosis admitted to our hospital with the complaints of vomiting, diarrhea and seizure. While he was hospitalized in a pediatric intensive care unit due to worsening of his signs related to cystinosis, within hours, he suffered complications of septic shock, acute renal failure, and disseminated intravascular coagulation, due to invasive Neisseria meningitidis serogroup W disease. Our patient is the first reported case of invasive meningococcal disease with cystinosis. Clinicians should consider that the unexpected and serious clinical findings of invasive meningococcal disease can mimic and/or masquerade as other metabolic diseases. Vaccination strategies, according to serogroup epidemiology and age distribution, should be implemented for the prevention of meningococcal infections.
Invasive meningococcal disease (IMD) results from infection with Neisseria meningitidis (N. meningitidis) and is associated with long-term sequelae and high case-fatality rates. The incidence of IMD is highest among children (especially infants). In addition to age, other risk factors include functional or anatomic asplenia, congenital complement deficiency and human immunodeficiency virus, taking eculizumab for paroxysmal nocturnal hemoglobinuria or atypical hemolytic uremic syndrome, being a laboratory worker, and attending mass gatherings.Citation1 Recently, Booy et al.Citation2 highlighted an increased rate of serogroup W IMD and/or the proportion of all IMD cases due to serogroup W (MenW) in Chile, Australia, United Kingdom and the Netherlands. The diversity and virulence of Men W strain variants have different clinical presentations, and which may result in increased mortality.Citation2,Citation3 Since 2005, Men W is one of the leading causes of bacterial meningitis and IMD among children.Citation4-6 Cystinosis, which is an autosomal recessive metabolic disease that is caused by mutations in the CTNS gene (located on the short arm of chromosome17), also causes dysfunction in the kidneys, corneas, bone marrow, thyroid, lymph nodes, liver, and spleen. Infantile nephropathic cystinosis (INC) is the most common and severe form of cystinosis.Citation7 To the best of our knowledge, there have been no reported cases of IMD among patients with cystinosis.
A nine-month-old boy who had been followed with a diagnosis of INC since five months of age was admitted with complaints from the parents of vomiting, diarrhea and seizure. Sixteen hours before his admission when at a routine medical visit, his physical examination and laboratory tests were within normal limits. He suffered vomiting and diarrhea within hours but did not receive his routine medications at that time. He was brought to the hospital by ambulance with generalized tonic seizures. At admission, his general condition was poor: he had tachypnea, tachycardia, an arterial blood pressure of 81/56 mmHg, a capillary refill time of 4 seconds, and a Glasgow Coma Score of 7. He was treated with intravenous glucose and calcium due to hypoglycemia and hypocalcemia and given a midazolam infusion. He was intubated, transferred to the intensive care unit, and immediately started on cefotaxime. Within two hours, the patient had hypotension, and his laboratory results showed anemia, thrombocytopenia, acute renal failure, and disseminated intravascular coagulation. The patient had hypotension despite inotrope infusion and had spontaneous rectal bleeding. Teicoplanin and polyclonal IgM-enriched intravenous IgG were administred. Because of his severe and sudden clinical course, we suspected IMD and serum RT-PCR showed MenW. On Day 5 of hospitalization, the clinical findings of infection regressed; however, the patient had severe neurological deficits. A cranial MRI examination showed several findings, which were interpreted as bleeding, edema, hypoxia secondary to meningococcemia, and delay in myelination secondary to metabolic disease. Antibiotic treatments were ceased on Day 10. We have continued to follow the patient in our outpatient clinic for INC with severe neurological sequelae.
Cystinosis requires continuous electrolyte replacement due to intense electrolyte loss, seizure, and shock.Citation7 IMD due to Men W, mainly new hypervirulent CC11 clones, might be present with gastrointestinal symptoms, such as vomiting and diarrhea as in this report.Citation3 In Turkey, an early period of surveillance study, which started in 2005, highlights the emergence of MenW strains which were closely related to the strain responsible for the MenW Hajj epidemic.Citation4 Thereafter, MenW has been one of the leading cause of IMD along with MenB.Citation5 MenW is also the main serogroup for meningococcal carriage among adolescents and young adults.Citation8 Our patient was the first reported case of IMD and cystinosis, and we found neither a risk association nor a pathophysiological explanation for this diagnosis. Clinicians should consider that the unexpected and serious clinical findings of IMD can mimic and/or masquerade as other metabolic diseases. Vaccination strategies, according to serogroup epidemiology and age distribution, should be implemented for the prevention of IMD.Citation1
Disclosure of potential conflicts of interest
EC Dinleyici has received grants to support research projects and consultancy fees from GSK, Pfizer and Sanofi Pasteur. Other authors declares no conflict of interest.
Additional information
Funding
References
- Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, Christensen H, Climent Y, De Wals P, Dinleyici EC, et al. The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019 Jan;18(1):15–30. doi:10.1080/14760584.2019.1557520.
- Booy R, Gentile A, Nissen M, Whelan J, Abitbol V. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Hum Vaccin Immunother. 2019;15(2):470–80. doi:10.1080/21645515.2018.1532248.
- Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, Taha MK. Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis. 2018 Sep 28;67(8):1220–27. doi:10.1093/cid/ciy257.
- Borrow R, Caugant DA, Ceyhan M, Christensen H, Dinleyici EC, Findlow J, Glennie L, Von Gottberg A, Kechrid A, Vázquez Moreno J, et al. Meningococcal disease in the Middle East and Africa: findings and updates from the global meningococcal initiative. J Infect. 2017;75(1):1–11. doi:10.1016/j.jinf.2017.04.007.
- Dinleyici EC, Ceyhan M. The dynamic and changing epidemiology of meningococcal disease at the country-based level: the experience in Turkey. Expert Rev Vaccines. 2012 May;11(5):515–18. doi:10.1586/erv.12.29.
- Ceyhan M, Ozsurekci Y, Bayhan C, Gurler N, Sali E, Keser Emiroglu M, Oz FN, Camcioglu Y, Salman N, Kurugol Z, et al. The changing epidemiology of bacterial meningitis during 2015–2017 in Turkey: a hospital-based prospective surveillance study. Open Forum Infect Dis. 2018;5(Suppl_1):S246. doi:10.1093/ofid/ofy210.689.
- Emma F, Nesterova G, Langman C, Labbé A, Cherqui S, Goodyer P, Janssen MC, Greco M, Topaloglu R, Elenberg E, et al. Nephropathic cystinosis: an international consensus document. Nephrol Dial Transplant. 2014 Sep;29(Suppl 4):iv87–94. doi:10.1093/ndt/gfu090.
- Tekin RT, Dinleyici EC, Ceyhan M, Karbuz A, Salman N, Sutçu M, Kurugol Z, Balliel Y, Celik M, Hacimustafaoglu M et al. The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey. Hum Vaccin Immunother. 2017 May 4;13(5):1182–89. doi:10.1080/21645515.2016.1268304.